Spark Biomedical Developing A Neurostimulation Device To Detect Opioid Withdrawal & Craving Symptoms

Spark Biomedical, Inc., is developing a wearable bioelectric treatment solution for opioid use disorder, and has joined forces with Battelle to jointly run a study to test a device to remotely detect and treat opioid withdrawal symptoms as part of a treatment solution. The study will use the device to collect physiological data via biosensors from people with opioid use disorder about their opioid withdrawal symptoms, cravings, and addiction-related psychological stressors. The jointly run pilot clinical study is estimated to begin in the summer of 2022 and run through the year.

From the data, the team will develop an . . .